1-6249561-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000377893.3(GPR153):āc.1607A>Cā(p.Glu536Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,187,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000377893.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR153 | NM_207370.4 | c.1607A>C | p.Glu536Ala | missense_variant | 6/6 | ENST00000377893.3 | NP_997253.2 | |
GPR153 | XM_011541434.4 | c.1607A>C | p.Glu536Ala | missense_variant | 6/6 | XP_011539736.1 | ||
GPR153 | XM_017001250.2 | c.1607A>C | p.Glu536Ala | missense_variant | 5/5 | XP_016856739.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR153 | ENST00000377893.3 | c.1607A>C | p.Glu536Ala | missense_variant | 6/6 | 1 | NM_207370.4 | ENSP00000367125 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000713 AC: 107AN: 150034Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000530 AC: 55AN: 1037536Hom.: 0 Cov.: 31 AF XY: 0.0000388 AC XY: 19AN XY: 489366
GnomAD4 genome AF: 0.000719 AC: 108AN: 150142Hom.: 0 Cov.: 32 AF XY: 0.000627 AC XY: 46AN XY: 73332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.1607A>C (p.E536A) alteration is located in exon 6 (coding exon 5) of the GPR153 gene. This alteration results from a A to C substitution at nucleotide position 1607, causing the glutamic acid (E) at amino acid position 536 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at